MapLight Therapeutics, Inc. (MPLT)

12.97 +0.37 (+2.94%) USD  |  NASDAQ  |  Aug 31, 16:00
13.02 +0.05 (+0.39%) After-Hours: 20:00
More

MapLight Therapeutics Cash and Short Term Investments (Quarterly) : 304.72M for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for MPLT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2024. Start Trial.
Date Value
June 30, 2026 304.72M
March 31, 2026 310.11M
December 31, 2025 305.10M
September 30, 2025 227.17M
Date Value
June 30, 2025 60.47M
March 31, 2025 92.26M
June 30, 2024
March 31, 2024 179.81M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Evommune, Inc. 200.79M
Sarepta Therapeutics, Inc. 788.49M
Cullinan Therapeutics, Inc. 334.54M
Mineralys Therapeutics, Inc. 661.41M
Apogee Therapeutics, Inc. 971.93M